Sartorius AG Stock
Stocks
SRT3
DE0007165631
Advanced Medical Equipment & Technology
OTC Markets Traded|
Market Closed -
Xetra
11:35:21 2026-10-23 EDT
|
5-day change | 1st Jan Change | ||
| 281.80 EUR | +3.03% |
|
+7.97% | +14.00% |
| 10-23 | Sartorius AG : Gets a Buy rating from Deutsche Bank | ZD |
| 10-23 | Sartorius AG : UBS keeps its Buy rating | ZD |
| Market Cap | 17.41B 19.49B 16.08B 14.57B 27.27B 1,851B 27.72B 194B 76.62B 970B 73.16B 71.6B 3,057B | P/E 2026 * |
71.2x | P/E 2027 * | 56x |
|---|---|---|---|---|---|
| Enterprise Value | 20.99B 23.51B 19.39B 17.57B 32.88B 2,231B 33.42B 233B 92.38B 1,169B 88.21B 86.34B 3,686B | EV / Sales 2026 * |
5.63x | EV / Sales 2027 * | 5.05x |
| Free-Float |
35.87% | Yield 2026 * |
0.28% | Yield 2027 * | 0.33% |
| Markets | Quality | ||
|---|---|---|---|
Xetra
| SRT3 | Delayed | |
CBOE
| SRT3d | Real-time | |
|
Tradegate
| SRT3 | Real-time | |
|
Boerse Muenchen
| SRT3 | Real-time | |
|
Börse Stuttgart
| SRT3 | Delayed | |
|
Deutsche Boerse AG
| SRT3 | Delayed | |
|
OTC Markets
| SUVPF | Delayed | |
|
Bulgaria S.E.
| SRT3 | End-of-day quote | |
|
London S.E.
| 0NIR | Delayed | |
|
CBOE
| 0NIR | Real-time | |
|
Swiss Exchange
| SRT3 | Delayed | |
|
Wiener Boerse
| SRT3 | End-of-day quote | |
|
Borsa Italiana
| 1SRT3 | End-of-day quote |
Last Transcript: Sartorius AG
| 1 day | +3.03% | ||
| 1 week | +7.97% | ||
| Current month | +8.64% | ||
| 1 month | +6.22% | ||
| 3 months | +27.51% | ||
| 6 months | +29.80% | ||
| Current year | +14.00% |
| 1 week | 255.6 |  | 282.9 |
| 1 month | 244.1 | | 282.9 |
| Current year | 198.5 | | 282.9 |
| 1 year | 198.5 | | 282.9 |
| 3 years | 166.05 | | 383.7 |
| 5 years | 166.05 | | 631.6 |
| 10 years | 63.65 | | 631.6 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Grosse
CEO | Chief Executive Officer | 59 | 2025-06-29 |
Florian Funck
DFI | Director of Finance/CFO | 55 | 2024-03-31 |
Volker Niebel
COO | Chief Operating Officer | 70 | 2000-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Annette Becker
BRD | Director/Board Member | 62 | 2002-08-31 |
Lothar Kappich
CHM | Chairman | 69 | 2017-07-18 |
| Director/Board Member | 77 | 2011-11-28 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 5/1/26 | Free | Executive/Senior Manager | 4,268 | 0.0114% | ||
| 5/1/26 | Free | Executive/Senior Manager | 5,203 | 0.0139% | ||
| 3/12/26 | Buy | Chairman | 191 | 0.0005% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.03% | +7.97% | +16.78% | +19.97% | 19.49B | |
| -0.40% | -2.34% | +17.70% | +47.04% | 249B | |
| +0.33% | +0.64% | +3.36% | +17.10% | 162B | |
| +1.90% | +6.00% | -17.24% | +63.05% | 157B | |
| -0.70% | +2.93% | -54.81% | -10.34% | 66.22B | |
| +0.15% | +4.09% | +10.25% | +63.82% | 52.3B | |
| +0.24% | +0.99% | -15.49% | -12.11% | 52.18B | |
| -1.13% | +2.85% | +17.04% | +26.36% | 51.34B | |
| -0.47% | +0.06% | +16.92% | +63.83% | 48.79B | |
| -0.42% | +3.83% | +26.19% | +82.07% | 44.57B | |
| Average | +0.25% | +2.83% | +2.07% | +36.08% | 90.3B | |
| Weighted average by Cap. | +0.21% | +1.64% | +1.71% | +38.67% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.73B 4.17B 3.44B 3.12B 5.84B 396B 5.94B 41.44B 16.41B 208B 15.67B 15.33B 655B | 4.1B 4.59B 3.79B 3.43B 6.42B 436B 6.53B 45.56B 18.04B 228B 17.22B 16.86B 720B |
| Net income | 258M 289M 238M 216M 404M 27.39B 410M 2.86B 1.13B 14.35B 1.08B 1.06B 45.24B | 330M 370M 305M 277M 517M 35.12B 526M 3.67B 1.45B 18.4B 1.39B 1.36B 58B |
| Net Debt | 3.58B 4.01B 3.31B 3B 5.61B 381B 5.7B 39.82B 15.77B 200B 15.06B 14.74B 629B | 3.28B 3.68B 3.03B 2.75B 5.14B 349B 5.23B 36.48B 14.44B 183B 13.79B 13.5B 576B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-23 | €281.80 | +3.03% | 133,058 |
| 26-10-22 | €273.50 | +4.75% | 262,546 |
| 26-10-21 | €261.10 | -1.36% | 221,032 |
| 26-10-20 | €264.70 | +1.65% | 108,835 |
| 26-10-19 | €260.40 | -0.23% | 81,723 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SRT3 Stock
Select your edition
All financial news and data tailored to specific country editions
